175 related articles for article (PubMed ID: 18298509)
1. To test or not to test during defibrillator implantation? A reassessment of the conventional wisdom.
Markowitz SM
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):406-8. PubMed ID: 18298509
[No Abstract] [Full Text] [Related]
2. Is defibrillation testing still necessary? A decision analysis and Markov model.
Gula LJ; Massel D; Krahn AD; Yee R; Skanes AC; Klein GJ
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):400-5. PubMed ID: 18298512
[TBL] [Abstract][Full Text] [Related]
3. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
5. Data analysis and interpretation of results in DATAS trial.
Vardanyan Z; Kanna B
Europace; 2008 Oct; 10(10):1243; author reply 1243-4. PubMed ID: 18796503
[No Abstract] [Full Text] [Related]
6. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
Köbe J; Eckardt L
Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
[No Abstract] [Full Text] [Related]
7. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
Hreybe H; Saba S
Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
Korantzopoulos P; Liu T; Li L; Goudevenos JA; Li G
Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
[TBL] [Abstract][Full Text] [Related]
9. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients.
Chen-Scarabelli C; Scarabelli TM
Pacing Clin Electrophysiol; 2007 Mar; 30(3):371-6. PubMed ID: 17367356
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality.
Goldenberg I; Moss AJ
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1281-3. PubMed ID: 18775038
[No Abstract] [Full Text] [Related]
11. Is anyone too old for an implantable cardioverter-defibrillator?
Heidenreich PA; Tsai V
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):6-8. PubMed ID: 20031806
[No Abstract] [Full Text] [Related]
12. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.
Kutalek SP; Sharma AD; McWilliams MJ; Wilkoff BL; Leonen A; Hallstrom AP; Kudenchuk PJ;
Pacing Clin Electrophysiol; 2008 Jul; 31(7):828-37. PubMed ID: 18684279
[TBL] [Abstract][Full Text] [Related]
13. Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: a measure of safety or out of date? A retrospective analysis of 975 patients.
Guenther M; Rauwolf T; Brüggemann B; Gerlach M; Wässnig NK; Christoph M; Braun MU; Strasser RH; Wunderlich C
Europace; 2012 Feb; 14(2):217-23. PubMed ID: 21969525
[TBL] [Abstract][Full Text] [Related]
14. Differences between women and men with ICDs: myth or reality?
Pelargonio G; Bisceglia C
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):979-81. PubMed ID: 19563354
[No Abstract] [Full Text] [Related]
15. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
Lehmann MH; Aaronson KD
J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
[No Abstract] [Full Text] [Related]
16. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator lead failure: how weak is the link?
Brinker JA
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
[TBL] [Abstract][Full Text] [Related]
19. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
[TBL] [Abstract][Full Text] [Related]
20. The burden of inappropriate shocks in young people and how to avoid them.
Upadhyay GA; Mela T; Singh JP
Heart; 2012 Oct; 98(19):1457-66. PubMed ID: 22965797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
